TY  - JOUR
AU  - Villar, Sara
AU  - Ariceta, Benat
AU  - Agirre, Xabier
AU  - Urribarri, Aura Daniela
AU  - Ayala, Rosa
AU  - Martinez-Cuadron, David
AU  - Miguel Bergua, Juan
AU  - Vives, Susana
AU  - Algarra, Lorenzo
AU  - Tormo, Mar
AU  - Martinez, Pilar
AU  - Serrano, Josefina
AU  - Simoes, Catia
AU  - Herrera, Pilar
AU  - Jose Calasanz, Maria
AU  - Alfonso-Pierola, Ana
AU  - Paiva, Bruno
AU  - Martinez-Lopez, Joaquin
AU  - San Miguel, Jesus F.
AU  - Prosper, Felipe
AU  - Montesinos, Pau
PY  - 2022
DO  - 10.3389/fonc.2022.1054458
SN  - 2234-943X
UR  - http://hdl.handle.net/10668/20688
T2  - Frontiers in oncology
AB  - Acute myeloid leukemia (AML) in the elderly remains a clinical challenge, with a five-year overall survival rate below 10%. The current ELN 2017 genetic risk classification considers cytogenetic and mutational characteristics to stratify fit AML...
LA  - en
PB  - Frontiers Research Foundation
KW  - B7-h3
KW  - Smar1
KW  - Expression
KW  - P53
KW  - Classification
KW  - Progression
KW  - Activation
KW  - Acute myeloid leukemia
KW  - Elderly
KW  - Transcriptomics
KW  - Biomarkers
KW  - Prognosis
KW  - Rna-seq
TI  - The transcriptomic landscape of elderly acute myeloid leukemia identifies B7H3 and BANP as a favorable signature in high-risk patients
TY  - research article
VL  - 12
ER  -